Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 19, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement
US Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement Post author:GHIAA Admin Post published:September 1, 2023 Post category: Continue ReadingUS Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement
NIH – Fluidigm, COVID-19 Diagnostic Development Agreement Post author:GHIAA Admin Post published:August 23, 2023 Post category: Continue ReadingNIH – Fluidigm, COVID-19 Diagnostic Development Agreement
MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 7, 2023 Post category: Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 6, 2023 Post category: Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 12, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement
FIND Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 7, 2022 Post category: Continue ReadingFIND Sample Funding Terms and Conditions
UnitaidExplore Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 1, 2022 Post category: Continue ReadingUnitaidExplore Sample Funding Terms and Conditions
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 8, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement